2 unknown, 1 completed, 1 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Unknown 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow SHR7390: new trials by email Literature Review of SHR7390 trials Research Report on SHR7390
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SHR7390 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer SHR7390 - Metastatic Castration-resistant Prostate Cancer | Phase 2 | Completed | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 6 | 2020-12-17 | 2023-06-13 |
| Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer SHR7390, Famitinib, SHR3162 - Breast Cancer, Metastatic Cancer | Phase 2 | Unknown | Fudan University | 319 | 2020-05-01 | 2022-07-26 |
| The Study of SHR7390 in Combination With SHR-1210 and SHR3162 in Patients With Advanced Solid Tumors SHR7390, SHR-1210, SHR3162 - Solid Tumor | Phase 1 | Terminated | Jiangsu HengRui Medicine Co., Ltd. | 31 | 2017-07-24 | 2022-09-01 |
| Phase I Study of SHR7390 in Patients With Advanced Solid Tumors SHR7390 - Solid Tumor | Phase 1 | Unknown | Jiangsu HengRui Medicine Co., Ltd. | 60 | 2016-11-01 | 2019-01-15 |
Breast Neoplasms (1) · Neoplasm Metastasis (1)
Jiangsu HengRui Medicine Co., Ltd. (2) · Fudan University (1) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)
China (4)
RuiHua Xu, MD, PhD (2) · Hongqian Guo (1) · Zhi-Ming Shao (1)